Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Phathom Pharmaceuticals (PHAT) Gross Profit (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Gross Profit for 4 consecutive years, with $46.3 million as the latest value for Q1 2026.

  • For Q1 2026, Gross Profit rose 86.75% year-over-year to $46.3 million; the TTM value through Mar 2026 reached $174.0 million, up 146.53%, while the annual FY2025 figure was $152.5 million, 222.58% up from the prior year.
  • Gross Profit hit $46.3 million in Q1 2026 for Phathom Pharmaceuticals, down from $49.9 million in the prior quarter.
  • Across five years, Gross Profit topped out at $49.9 million in Q4 2025 and bottomed at $515000.0 in Q4 2023.
  • Average Gross Profit over 4 years is $24.7 million, with a median of $25.3 million recorded in 2024.
  • Year-over-year, Gross Profit skyrocketed 4919.22% in 2024 and then skyrocketed 86.75% in 2026.
  • Phathom Pharmaceuticals' Gross Profit stood at $515000.0 in 2023, then surged by 4919.22% to $25.8 million in 2024, then soared by 93.18% to $49.9 million in 2025, then dropped by 7.27% to $46.3 million in 2026.
  • According to Business Quant data, Gross Profit over the past three periods came in at $46.3 million, $49.9 million, and $43.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.